Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
lighter decrease » slightly decreases (Expand Search), larger decrease (Expand Search), greater decrease (Expand Search)
slight decrease » slight increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
lighter decrease » slightly decreases (Expand Search), larger decrease (Expand Search), greater decrease (Expand Search)
slight decrease » slight increase (Expand Search)
-
361
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …”
-
362
-
363
-
364
-
365
Facilities offering modern family planning services by division in 2014 (A) and 2017 (B).
Published 2025Subjects: -
366
-
367
-
368
Modern family planning service readiness score by division in 2014 (A) and 2017 (B).
Published 2025Subjects: -
369
-
370
Mean readiness score of modern family planning service by facility type in 2014 and 2017.
Published 2025Subjects: -
371
Overall and domain-specific mean readiness score by survey years, 2014 and 2017.
Published 2025Subjects: -
372
Percentage distribution (weighted) of surveyed facilities in 2014 and 2017.
Published 2025Subjects: -
373
-
374
-
375
-
376
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
377
-
378
-
379
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
380
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”